DiscoverERS Publications PodcastsERJ Podcast June 2024: Inhaled treprostinil in pulmonary hypertension associated with COPD
ERJ Podcast June 2024: Inhaled treprostinil in pulmonary hypertension associated with COPD

ERJ Podcast June 2024: Inhaled treprostinil in pulmonary hypertension associated with COPD

Update: 2024-07-01
Share

Description

As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Steven D. Nathan (Inova Fairfax Hospital, Falls Church, VA, USA) about the PERFECT study, which showed that inhaled treprostinil does not demonstrate a positive risk–benefit ratio in favour of treatment in pulmonary hypertension associated with COPD.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ERJ Podcast June 2024: Inhaled treprostinil in pulmonary hypertension associated with COPD

ERJ Podcast June 2024: Inhaled treprostinil in pulmonary hypertension associated with COPD

ERS Publications Podcasts